Transplantation in Acute Myeloid Leukemia, Hematology/Oncology Clinics of North America, vol.28, issue.6, pp.983-994, 2014. ,
DOI : 10.1016/j.hoc.2014.08.016
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach, Nature Reviews Clinical Oncology, vol.108, issue.10, pp.579-590, 2012. ,
DOI : 10.1182/blood-2005-10-4165
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease???Based Definition of Complete Remission?, Journal of Clinical Oncology, vol.34, issue.4, pp.329-336, 2016. ,
DOI : 10.1200/JCO.2015.63.3826
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report, Bone Marrow Transplantation, vol.118, issue.6, pp.811-817, 2017. ,
DOI : 10.1182/blood-2011-03-344853
How to select the best available related or unrelated donor of hematopoietic stem cells?, Haematologica, vol.101, issue.6, pp.680-687, 2016. ,
DOI : 10.3324/haematol.2015.141119
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry, New England Journal of Medicine, vol.371, issue.4, pp.339-348, 2014. ,
DOI : 10.1056/NEJMsa1311707
On Modeling Human Leukocyte Antigen???Identical Sibling Match Probability for Allogeneic Hematopoietic Cell Transplantation: Estimating the Need for an Unrelated Donor Source, Biology of Blood and Marrow Transplantation, vol.22, issue.3, pp.410-417, 2016. ,
DOI : 10.1016/j.bbmt.2015.09.012
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia, Leukemia, vol.15, issue.5, pp.1069-1075, 2015. ,
DOI : 10.1182/blood-2011-03-344853
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplantation, vol.8, issue.4, pp.476-482, 2015. ,
DOI : 10.1016/j.bbmt.2014.05.015
Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings, New England Journal of Medicine, vol.313, issue.13, pp.765-771, 1985. ,
DOI : 10.1056/NEJM198509263131301
Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or Lymphoma, New England Journal of Medicine, vol.320, issue.4, pp.197-204, 1989. ,
DOI : 10.1056/NEJM198901263200401
Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma, Human Immunology, vol.29, issue.2, pp.79-91, 1990. ,
DOI : 10.1016/0198-8859(90)90071-V
MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA, The Lancet, vol.321, issue.8325, pp.612-615, 1983. ,
DOI : 10.1016/S0140-6736(83)91793-2
Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colonystimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum, Blood, vol.84, issue.11, pp.3948-3955, 1994. ,
Treatment of High-Risk Acute Leukemia with T-Cell???Depleted Stem Cells from Related Donors with One Fully Mismatched HLA Haplotype, New England Journal of Medicine, vol.339, issue.17, pp.1186-1193, 1998. ,
DOI : 10.1056/NEJM199810223391702
Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse, Journal of Clinical Oncology, vol.23, issue.15, pp.3447-3454, 2005. ,
DOI : 10.1200/JCO.2005.09.117
Setting the standard in T-cell-depleted haploidentical transplantation and beyond, Best Practice & Research Clinical Haematology, vol.24, issue.3, pp.325-329, 2011. ,
DOI : 10.1016/j.beha.2011.04.008
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation, Blood, vol.128, issue.23, pp.2616-2623, 2016. ,
DOI : 10.1182/blood-2016-07-730564
Role of natural killer cell alloreactivity in HLAmismatched hematopoietic stem cell transplantation, Blood, vol.94, issue.1, pp.333-339, 1999. ,
Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants, Science, vol.295, issue.5562, pp.2097-2100, 2002. ,
DOI : 10.1126/science.1068440
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value., Blood, vol.110, issue.1, pp.433-440, 2007. ,
DOI : 10.1182/blood-2006-07-038687
Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia, Current Opinion in Immunology, vol.21, issue.5, pp.525-530, 2009. ,
DOI : 10.1016/j.coi.2009.07.015
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation, Blood, vol.112, issue.9, pp.3574-3581, 2008. ,
DOI : 10.1182/blood-2008-02-140095
Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study, The Lancet, vol.360, issue.9327, pp.130-137, 2002. ,
DOI : 10.1016/S0140-6736(02)09413-8
Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation, Blood, vol.108, issue.6, pp.1797-1808, 2006. ,
DOI : 10.1182/blood-2006-02-001909
URL : http://www.bloodjournal.org/content/bloodjournal/108/6/1797.full.pdf
Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies, Bone Marrow Transplantation, vol.23, issue.7, pp.968-977, 2015. ,
DOI : 10.1200/JCO.2005.09.117
URL : http://www.nature.com/bmt/journal/v50/n7/pdf/bmt2014324a.pdf
Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation, The Journal of Experimental Medicine, vol.131, issue.3, pp.389-399, 2002. ,
DOI : 10.4049/jimmunol.164.1.183
URL : http://jem.rupress.org/content/jem/196/3/389.full.pdf
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation, Blood, vol.111, issue.2, pp.945-953, 2008. ,
DOI : 10.1182/blood-2007-07-103895
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation, Blood, vol.117, issue.14, pp.3921-3928, 2011. ,
DOI : 10.1182/blood-2010-10-311894
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse, Blood, vol.124, issue.4, pp.638-644, 2014. ,
DOI : 10.1182/blood-2014-03-564401
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I???II study, The Lancet Oncology, vol.10, issue.5, pp.489-500, 2009. ,
DOI : 10.1016/S1470-2045(09)70074-9
Prolongation of Homograft Survival in Mice with Single Doses of Cyclophosphamide, Nature, vol.200, issue.4901, p.84, 1963. ,
DOI : 10.1016/0006-2952(62)90088-6
Dose-response relationships for agents inhibiting the immune response, Immunology, vol.7, pp.65-71, 1964. ,
Production of Graft-Versus-Host Disease in the Rat and its Treatment with Cytotoxic Agents, Nature, vol.32, issue.5032, pp.139-140, 1966. ,
DOI : 10.1084/jem.118.4.635
DRUG-INDUCED TOLERANCE TO ALLOGRAFTS IN MICE: VI. TOLERANCE INDUCTION IN H-2-HAPLOTYPE-IDENTICAL STRAIN COMBINATIONS IN MICE, Transplantation, vol.40, issue.2, pp.188-194, 1985. ,
DOI : 10.1097/00007890-198508000-00016
Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide, Blood, vol.98, issue.12, pp.3456-3464, 2001. ,
DOI : 10.1182/blood.V98.12.3456
Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation, Biology of Blood and Marrow Transplantation, vol.8, issue.3, pp.131-138, 2002. ,
DOI : 10.1053/bbmt.2002.v8.pm11939602
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide, Science Translational Medicine, vol.82, issue.1, pp.211-157, 2013. ,
DOI : 10.1097/01.tp.0000225824.48931.af
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155575/pdf
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells, Blood, vol.75, issue.10, pp.1947-1950, 1990. ,
Assessment of aldehyde dehydrogenase in viable cells, Blood, vol.85, issue.10, pp.2742-2746, 1995. ,
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.8, issue.7, pp.377-386, 2002. ,
DOI : 10.1053/bbmt.2002.v8.pm12171484
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.14, issue.6, pp.641-650, 2008. ,
DOI : 10.1016/j.bbmt.2008.03.005
URL : https://doi.org/10.1016/j.bbmt.2008.03.005
HLA-haploidentical Marrow Transplant, pp.844-852, 2007. ,
Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies, Bone Marrow Transplantation, vol.26, issue.Suppl 1, pp.291-297, 2006. ,
DOI : 10.1532/IJH97.A10227
Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, vol.15, issue.2, pp.257-265, 2009. ,
DOI : 10.1016/j.bbmt.2008.11.025
Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia, Cancer, vol.17, issue.5, pp.978-985, 2013. ,
DOI : 10.1016/j.bbmt.2010.08.023
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT, Blood, vol.124, issue.17, pp.2735-2743, 2014. ,
DOI : 10.1182/blood-2014-04-571570
URL : http://www.bloodjournal.org/content/bloodjournal/124/17/2735.full.pdf
Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison, Biology of Blood and Marrow Transplantation, vol.17, issue.6, pp.821-830, 2011. ,
DOI : 10.1016/j.bbmt.2010.08.023
HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: Long-term comparison with HLA-identical sibling transplantation, Blood Cells, Molecules, and Diseases, vol.43, issue.1, pp.98-104, 2009. ,
DOI : 10.1016/j.bcmd.2009.02.005
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation, Blood, vol.107, issue.8, pp.3065-3073, 2006. ,
DOI : 10.1182/blood-2005-05-2146
URL : http://www.bloodjournal.org/content/bloodjournal/107/8/3065.full.pdf
Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study, Blood, vol.125, issue.25, pp.3956-3962, 2015. ,
DOI : 10.1182/blood-2015-02-627786
URL : http://www.bloodjournal.org/content/bloodjournal/125/25/3956.full.pdf
Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database, Haematologica, vol.101, issue.8, pp.352-354, 2016. ,
DOI : 10.3324/haematol.2015.140509
-host disease prophylaxis in haploidentical transplant, Haematologica, vol.102, issue.2, pp.401-410, 2017. ,
DOI : 10.3324/haematol.2016.151779
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning, Biology of Blood and Marrow Transplantation, vol.19, issue.1, pp.117-122, 2013. ,
DOI : 10.1016/j.bbmt.2012.08.014
URL : https://doi.org/10.1016/j.bbmt.2012.08.014
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update, Bone Marrow Transplantation, vol.50, issue.2, pp.37-39, 2015. ,
DOI : 10.1016/j.bbmt.2012.08.014
URL : http://www.nature.com/bmt/journal/v50/n2s/pdf/bmt201593a.pdf
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial, Biology of Blood and Marrow Transplantation, vol.18, issue.12, pp.1859-1866, 2012. ,
DOI : 10.1016/j.bbmt.2012.06.019
Total Body Irradiation???Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors, Biology of Blood and Marrow Transplantation, vol.21, issue.7, pp.1299-1307, 2015. ,
DOI : 10.1016/j.bbmt.2015.03.003
Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT, Journal of Hematology & Oncology, vol.69, issue.2, p.25, 2016. ,
DOI : 10.1016/0002-9343(80)90380-0
URL : https://hal.archives-ouvertes.fr/hal-01297485
Use of bone marrow or peripheral blood stem cell grafts in non T cell depleted haploidentical transplants using post-transplant cyclophosphamide, an ALWP-EBMT analysis, 2016. ,
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors, Leukemia, vol.707, issue.2, pp.396-405, 2015. ,
DOI : 10.1182/blood-2013-08-519413
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells, Biology of Blood and Marrow Transplantation, vol.21, issue.8, pp.1506-1514, 2015. ,
DOI : 10.1016/j.bbmt.2015.04.025
URL : https://doi.org/10.1016/j.bbmt.2015.04.025
Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.20, issue.5, pp.724-729, 2014. ,
DOI : 10.1016/j.bbmt.2014.02.001
URL : https://doi.org/10.1016/j.bbmt.2014.02.001
Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis, Bone Marrow Transplantation, vol.23, issue.12, pp.1599-1601, 2016. ,
DOI : 10.1126/scitranslmed.3006960
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults, Journal of Clinical Oncology, vol.33, issue.28, pp.3152-3161, 2015. ,
DOI : 10.1200/JCO.2014.60.4777
Haploidentical T Cell???Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen???Matched Related or Unrelated Donor, Biology of Blood and Marrow Transplantation, vol.22, issue.1, pp.119-124, 2016. ,
DOI : 10.1016/j.bbmt.2015.08.029
Impact of ABO incompatibility on patients??? outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT, Haematologica, vol.102, issue.6, pp.1066-1074, 2017. ,
DOI : 10.3324/haematol.2016.160804
Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia, Journal of Clinical Oncology, vol.29, issue.9, pp.1190-1197, 2011. ,
DOI : 10.1200/JCO.2010.31.8121
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission, Blood, vol.122, issue.10, pp.1813-1821, 2013. ,
DOI : 10.1182/blood-2013-06-506725
Assessment of Minimal Residual Disease in Standard-Risk AML, New England Journal of Medicine, vol.374, issue.5, pp.422-433, 2016. ,
DOI : 10.1056/NEJMoa1507471
Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML, Bone Marrow Transplantation, vol.88, issue.5, pp.679-683, 2014. ,
DOI : 10.1016/j.leukres.2010.12.013
URL : http://www.nature.com/bmt/journal/v49/n5/pdf/bmt20149a.pdf
Variable outcome of allogeneic stem cell transplant according to the different levels of pre-transplant minimal residual disease, in adult patients with acute myeloid leukemia, Blood, vol.126, issue.23, p.3230, 2015. ,
Impact of Pretransplantation Risk Factors on Post Transplantation Outcome of Patients with Acute Myeloid Leukemia in Remission after Haploidentical Hematopoietic Stem Cell??Transplantation, Biology of Blood and Marrow Transplantation, vol.19, issue.2, pp.283-290, 2013. ,
DOI : 10.1016/j.bbmt.2012.10.002
The impact of minimal residual disease prior to unmanipulated haploidentical hematopoietic stem cell transplantation in patients with acute myeloid leukemia in complete remission, Leukemia & Lymphoma, vol.126, issue.5, pp.1135-1143, 2017. ,
DOI : 10.1007/s00277-013-1733-1
Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation, Blood, vol.129, issue.22, pp.3031-3033, 2017. ,
DOI : 10.1182/blood-2017-02-766154
Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States, Biology of Blood and Marrow Transplantation, vol.22, issue.1, pp.23-26, 2016. ,
DOI : 10.1016/j.bbmt.2015.11.001
IMMUNITY TO INFECTIONS AFTER HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION, Mediterranean Journal of Hematology and Infectious Diseases, vol.8, issue.1, p.2016057, 2016. ,
DOI : 10.4084/mjhid.2016.057
URL : http://www.mjhid.org/index.php/mjhid/article/download/2016.057/pdf
Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation, Cancer, vol.91, issue.suppl 7, pp.1800-1809, 2017. ,
DOI : 10.1007/s00277-012-1541-z
Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy, Biology of Blood and Marrow Transplantation, vol.23, issue.4, pp.612-617, 2017. ,
DOI : 10.1016/j.bbmt.2016.12.640
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?, Journal of Hematology & Oncology, vol.121, issue.20, p.35, 2016. ,
DOI : 10.1182/blood-2012-11-468348
URL : https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-016-0265-2?site=jhoonline.biomedcentral.com
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis, Haematologica, vol.100, issue.4, pp.558-564, 2015. ,
DOI : 10.3324/haematol.2014.111450
URL : http://www.haematologica.org/content/haematol/100/4/558.full.pdf
Modern approaches to HLA-haploidentical blood or marrow transplantation, Nature Reviews Clinical Oncology, vol.5, issue.1, pp.10-24, 2016. ,
DOI : 10.1182/blood-2007-03-082933
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695979/pdf